Personal tools

MCL coexpression mm9:160

From FANTOM5_SSTAR

Revision as of 11:03, 11 October 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Phase1 CAGE Peaks

 Short description
Mm9::chr10:40423484..40423502,+p@chr10:40423484..40423502
+
Mm9::chr10:80267978..80267994,+p1@Amh
Mm9::chr10:80269144..80269155,+p@chr10:80269144..80269155
+
Mm9::chr10:80270378..80270405,-p@chr10:80270378..80270405
-
Mm9::chr11:100939668..100939675,+p5@Hsd17b1
Mm9::chr11:64252028..64252033,+p@chr11:64252028..64252033
+
Mm9::chr11:78218076..78218085,-p@chr11:78218076..78218085
-
Mm9::chr11:78218088..78218109,-p@chr11:78218088..78218109
-
Mm9::chr11:78218124..78218138,-p@chr11:78218124..78218138
-
Mm9::chr12:70419557..70419568,-p@chr12:70419557..70419568
-
Mm9::chr13:22002790..22002800,+p@chr13:22002790..22002800
+
Mm9::chr13:22002808..22002818,+p@chr13:22002808..22002818
+
Mm9::chr13:22002835..22002844,+p@chr13:22002835..22002844
+
Mm9::chr13:22027290..22027293,+p@chr13:22027290..22027293
+
Mm9::chr13:22028056..22028060,+p@chr13:22028056..22028060
+
Mm9::chr13:64190777..64190808,-p7@Hsd17b3
Mm9::chr14:26688270..26688295,+p@chr14:26688270..26688295
+
Mm9::chr14:26688313..26688342,+p@chr14:26688313..26688342
+
Mm9::chr14:63940369..63940380,-p@chr14:63940369..63940380
-
Mm9::chr14:63940381..63940388,-p@chr14:63940381..63940388
-
Mm9::chr14:63940401..63940406,-p@chr14:63940401..63940406
-
Mm9::chr15:51621796..51621814,-p@chr15:51621796..51621814
-
Mm9::chr15:51621825..51621843,-p@chr15:51621825..51621843
-
Mm9::chr15:98728889..98728898,-p2@Dhh
Mm9::chr16:57350661..57350691,-p@chr16:57350661..57350691
-
Mm9::chr17:26343402..26343411,-p@chr17:26343402..26343411
-
Mm9::chr17:26343432..26343443,-p@chr17:26343432..26343443
-
Mm9::chr17:28644419..28644434,-p9@Fkbp5
Mm9::chr17:28644459..28644474,-p7@Fkbp5
Mm9::chr17:89026087..89026115,+p4@Ston1
Mm9::chr19:46747373..46747390,-p1@Cyp17a1
Mm9::chr1:157079806..157079834,-p1@uc007dbe.1
Mm9::chr1:157079840..157079859,-p1@BC034090
Mm9::chr1:34154110..34154139,+p@chr1:34154110..34154139
+
Mm9::chr2:148625363..148625390,+p@chr2:148625363..148625390
+
Mm9::chr2:148625392..148625410,+p@chr2:148625392..148625410
+
Mm9::chr2:148625440..148625453,+p@chr2:148625440..148625453
+
Mm9::chr2:148625478..148625492,+p@chr2:148625478..148625492
+
Mm9::chr2:74976903..74976916,+p@chr2:74976903..74976916
+
Mm9::chr3:138189138..138189142,+p1@Eif4e
Mm9::chr3:87587211..87587233,-p3@Ntrk1
Mm9::chr4:107020023..107020048,+p@chr4:107020023..107020048
+
Mm9::chr4:140652853..140652865,+p@chr4:140652853..140652865
+
Mm9::chr4:140652996..140653007,+p@chr4:140652996..140653007
+
Mm9::chr4:43270640..43270649,+p@chr4:43270640..43270649
+
Mm9::chr4:43270733..43270747,+p@chr4:43270733..43270747
+
Mm9::chr5:65438116..65438120,-p@chr5:65438116..65438120
-
Mm9::chr5:73008621..73008630,-p@chr5:73008621..73008630
-
Mm9::chr5:75547405..75547425,+p@chr5:75547405..75547425
+
Mm9::chr5:75548184..75548211,+p5@Pdgfra
Mm9::chr5:75548299..75548322,+p3@Pdgfra
Mm9::chr5:75548341..75548392,+p1@Pdgfra
Mm9::chr6:48389611..48389623,-p@chr6:48389611..48389623
-
Mm9::chr7:104599810..104599819,+p3@Kctd14
Mm9::chr7:104599826..104599841,+p2@Kctd14
Mm9::chr7:109015811..109015852,-p6@Folr1
Mm9::chr7:124523532..124523544,+p@chr7:124523532..124523544
+
Mm9::chr7:133016191..133016234,+p@chr7:133016191..133016234
+
Mm9::chr7:134830340..134830354,-p@chr7:134830340..134830354
-
Mm9::chr7:151635672..151635690,-p2@Cttn
Mm9::chr7:52312425..52312434,-p@chr7:52312425..52312434
-
Mm9::chr8:73162767..73162778,-p@chr8:73162767..73162778
-
Mm9::chr8:74210633..74210673,+p@chr8:74210633..74210673
+
Mm9::chr8:74210687..74210707,+p@chr8:74210687..74210707
+
Mm9::chr8:80248811..80248822,-p9@Ednra
Mm9::chr8:97334346..97334361,+p1@Ccl17
Mm9::chr9:45136577..45136591,+p@chr9:45136577..45136591
+
Mm9::chr9:86651061..86651063,+p@chr9:86651061..86651063
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0045137development of primary sexual characteristics0.00564388892742367
GO:0006694steroid biosynthetic process0.00564388892742367
GO:0007548sex differentiation0.00564388892742367
GO:0003006reproductive developmental process0.0069094056575987
GO:0016229steroid dehydrogenase activity0.0134672247436423
GO:0046546development of primary male sexual characteristics0.0135048765320258
GO:0046661male sex differentiation0.0146140807144875
GO:0008202steroid metabolic process0.0146140807144875
GO:0042446hormone biosynthetic process0.0222495706780046
GO:0007506gonadal mesoderm development0.0257206979977026
GO:0046655folic acid metabolic process0.0257206979977026
GO:0004508steroid 17-alpha-monooxygenase activity0.0257206979977026
GO:0047045testosterone 17-beta-dehydrogenase (NADP+) activity0.0257206979977026
GO:0022414reproductive process0.0257206979977026
GO:0008406gonad development0.0267817631548365
GO:0048608reproductive structure development0.0271045687618472
GO:0008610lipid biosynthetic process0.0289954205108826
GO:0004714transmembrane receptor protein tyrosine kinase activity0.0289954205108826
GO:0005515protein binding0.0289954205108826
GO:0008429phosphatidylethanolamine binding0.0289954205108826
GO:0006703estrogen biosynthetic process0.0289954205108826
GO:0004962endothelin receptor activity0.0289954205108826
GO:0048407platelet-derived growth factor binding0.0289954205108826
GO:0033327Leydig cell differentiation0.0289954205108826
GO:0019199transmembrane receptor protein kinase activity0.0306867376359688
GO:0042445hormone metabolic process0.0306867376359688
GO:0030809negative regulation of nucleotide biosynthetic process0.0306867376359688
GO:0006620posttranslational protein targeting to membrane0.0306867376359688
GO:0030908protein splicing0.0306867376359688
GO:0030818negative regulation of cAMP biosynthetic process0.0306867376359688
GO:0016539intein-mediated protein splicing0.0306867376359688
GO:0030815negative regulation of cAMP metabolic process0.0306867376359688
GO:0030803negative regulation of cyclic nucleotide biosynthetic process0.0306867376359688
GO:0030800negative regulation of cyclic nucleotide metabolic process0.0306867376359688
GO:0008210estrogen metabolic process0.0375225372766592
GO:0045980negative regulation of nucleotide metabolic process0.0375225372766592
GO:0008517folic acid transporter activity0.0375225372766592
GO:0009058biosynthetic process0.0375225372766592
GO:0030817regulation of cAMP biosynthetic process0.0434324089209833
GO:0006704glucocorticoid biosynthetic process0.0434324089209833
GO:0016616oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor0.0445127194766519
GO:0030539male genitalia development0.047248571028189
GO:0005160transforming growth factor beta receptor binding0.047248571028189
GO:0030814regulation of cAMP metabolic process0.047248571028189
GO:0016614oxidoreductase activity, acting on CH-OH group of donors0.047248571028189



Relative expression of the co-expression cluster over median <br>Analyst:



"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}